Piramal Enterprises Limited
The current stock price of Piramal Enterprises Limited is ₹1,048.90, with a target price range between ₹996.46 and ₹1,101.35. The stock has experienced a price change of ₹2.45 (0.23%), reflecting recent market volatility.
Today's opening price was ₹1,050.00, while the previous close stood at ₹1,046.45. The intraday high reached ₹1,060.20, and the low touched ₹1,045.80. The volume-weighted average price (VWAP) is currently ₹1,054.11, indicating the stock's average traded price.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Piramal Enterprises Limited Price Chart
Piramal Enterprises Limited Pre Open Market Overview: 05-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1050
- Previous Close Price: 1046.45
- Change: 3.55%
- Total Traded Volume: 928
- Total Buy Quantity: 3,557
- Total Sell Quantity: 7,494
Price | Buy Qty | Sell Qty |
---|---|---|
1,046.60 | 3.00 | 0.00 |
1,047.00 | 317.00 | 0.00 |
1,047.25 | 21.00 | 0.00 |
1,048.00 | 62.00 | 0.00 |
1,049.00 | 100.00 | 0.00 |
1,050.00 | 0.00 | 290.00 |
1,051.00 | 0.00 | 25.00 |
1,051.15 | 0.00 | 2,276.00 |
1,051.60 | 0.00 | 14.00 |
1,051.70 | 0.00 | 5.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns (in %) of Piramal Enterprises Limited
Category | 31-Dec-2023 | 31-Mar-2024 | 30-Jun-2024 | 30-Sep-2024 | 31-Dec-2024 |
---|---|---|---|---|---|
Promoter & Promoter Group | 46.19 | 46.19 | 46.03 | 46.30 | 46.30 |
Public | 53.31 | 53.31 | 53.48 | 53.29 | 53.33 |
Shares held by Employee Trusts | 0.50 | 0.49 | 0.50 | 0.41 | 0.37 |
Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Key Trade Statistics of Piramal Enterprises Limited
The trade information for Piramal Enterprises Limited includes a total traded volume of 3.56 lakh shares, and a traded value of ₹37.54 crore.
The market cap is ₹23,650.36 crore, with a free float market cap of ₹12,492.61 crore. The deliverable quantity is 145,574.00 shares, reflecting 40.88% of total trades.
Key risk indicators include security VaR at 15.95% and an applicable margin rate of 19.45%.
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 3.56 |
Traded Value (₹ Cr.) | 37.54 |
Total Market Cap (₹ Cr.) | 23,650.36 |
Free Float Market Cap (₹ Cr.) | 12,492.61 |
Impact cost | 0.04 |
Quantity Traded | 356,118.00 |
Deliverable Quantity | 145,574.00 |
% of Quantity to Traded | 40.88 |
Security VaR | 15.95 |
Index VaR | N/A |
VaR Margin | 15.95 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 19.45 |
Face Value | 2 |
Key Price Statistics of Piramal Enterprises Limited
The 52-week high for Piramal Enterprises Limited was ₹1,275.00, recorded on 12-Dec-2024. On the other hand, the 52-week low stands at ₹736.60, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹N/A, and the lower band is ₹N/A. The price band is No Band%.
The stock's daily volatility stands at 2.47, while the annualized volatility is 47.19. The tick size for trading is ₹N/A.
Price Information | Details |
---|---|
52 Week High (12-Dec-2024) | 1,275.00 |
52 Week Low (04-Jun-2024) | 736.60 |
Upper Band | 1,151.05 |
Lower Band | 941.80 |
Price Band (%) | No Band |
Daily Volatility | 2.47 |
Annualised Volatility | 47.19 |
Tick Size | 0.05 |
Key Securities Statistics of Piramal Enterprises Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 08-Feb-1995 |
Adjusted P/E | 0 |
Symbol P/E | 48.69 |
Index | NIFTY 500 |
Macro-Economic Sector | Financial Services |
Sector | Financial Services |
Industry | Finance |
Basic Industry | Non Banking Financial Company (NBFC) |
Security Status of Piramal Enterprises Limited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Piramal Enterprises Limited
Subject | Date |
---|---|
Analysts/Institutional Investor Meet/Con. Call Updates | 04-Feb-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 31-Jan-2025 |
Updates | 28-Jan-2025 |
Integrated Filing- Financial | 27-Jan-2025 |
Updates | 27-Jan-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 27-Jan-2025 |
Press Release | 27-Jan-2025 |
Outcome of Board Meeting | 27-Jan-2025 |
Corporate Actions of Piramal Enterprises Limited
Face Value | Purpose | Ex-Date |
---|---|---|
2 | Dividend - Rs 10 Per Share | 05-Jul-2024 |
2 | Buy Back | 25-Aug-2023 |
2 | Dividend - Rs 31 Per Sh | 16-Jun-2023 |
2 | Demerger | 30-Aug-2022 |
2 | Dividend - Rs 33 Per Share | 14-Jul-2022 |
2 | Dividend - Rs 33 Per Share | 06-Jul-2021 |
2 | Annual General Meeting/Dividend - Rs 14 Per Share | 16-Jul-2020 |
2 | Rights 11:83 @ Premium Rs 1298/- | 30-Dec-2019 |
2 | Annual General Meeting/ Dividend - Rs 28 Per Share | 18-Jul-2019 |
2 | Dividend- Rs 25 Per Share | 19-Jul-2018 |
2 | Rights 1:23 @ Premium Rs 2378/- | 31-Jan-2018 |
2 | Dividend - Rs 21/- Per Share | 21-Jul-2017 |
2 | Interim Dividend -Rs 17.50/- Per Share | 17-Mar-2016 |
2 | Annual General Meeting/ Dividend - Rs 20/- Per Share | 28-Jul-2015 |
2 | Annual General Meeting / Dividend - Rs 52.5/- Per Share | 15-Jul-2014 |
2 | Annual General Meeting And Dividend Rs.17.50 Per Equity Share | 15-Jul-2013 |
2 | Annual General Meeting And Dividend Rs.17.50 Per Share | 09-Jul-2012 |
2 | Final Dividend Rs.6/- Per Share And Special Dividend Rs.6/- Per Share | 28-Jul-2011 |
2 | Dividend-Rs.5.40 Per Share | 29-Jun-2010 |
2 | Agm/Div-Rs.4.20 Per Share | 05-Jun-2009 |
Board Meetings of Piramal Enterprises Limited
Financial Results of Piramal Enterprises Limited
Qtr Ended | Tot. Income | Net P/L | EPS | Notes |
---|---|---|---|---|
31 Dec 2024 | 45,684 | 18,330 | 8.13 | |
30 Sep 2024 | 52,234 | 11,569 | 5.13 | |
30 Jun 2024 | 55,663 | 22,807 | 10.14 | |
31 Mar 2024 | 143,369 | 95,354 | 42.44 | |
31 Dec 2023 | 69,884 | -105,953 | -47.16 |
Company Directory of Piramal Enterprises Limited
Web Address | Office | Address | City |
---|---|---|---|
N/A | Head Office/ Corporate Office | Piramal Agastya Corporate Park, B-Wing, Ground Floor, Opposite Fire Brigade, Kamani Junction, Kurla (West) | MUMBAI |
N/A | Registered Office | Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction LBS Marg, Kurla (West) Mumbai 400070 | MUMBAI |
N/A | Transfer Agent | Link Intime India Private Limited C 101, 247 Park, L B S Marg, Vikhroli West, | MUMBAI |
Insider Trading of Piramal Enterprises Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | Krishna Kumar | 44863440 | Buy |
7(2) | Piramal Enterprises Limited Senior Employees Welfare Trust | 44863396 | Sell |
7(2) | Krishna Kumar | 44863440 | Sell |
7(2) | Somanahalli Krishna Honnesh | 11440000 | Buy |
7(2) | Piramal Enterprises Limited Senior Employees Welfare Trust | 56659031 | Sell |
7(2) | Piramal Welfare Trust | 24707902 | Sell |
7(2) | Somanahalli Krishna Honnesh | 11440000 | Sell |
7(2) | Ujwal Prakash Shendre | 9432800 | Buy |
7(2) | Piramal Enterprises Limited Senior Employees Welfare Trust | 72795782 | Sell |
7(2) | Piramal Enterprises Limited Senior Employees Welfare Trust | 12847684 | Sell |
7(2) | Sachin Deodhar | 56659031 | Sell |
7(2) | Sachin Deodhar | 56659031 | Buy |
7(2) | Sachin Deodhar | 51922982 | Sell |
7(2) | Sachin Deodhar | 51922982 | Buy |
7(2) | Sachin Deodhar | 12847684 | Sell |
7(2) | Sachin Deodhar | 12847684 | Buy |
7(2) | Ujwal Prakash Shendre | 9432800 | Sell |
7(2) | Jairam Sridharan | 4019811 | Buy |
7(2) | Jairam Sridharan | 3005989 | Buy |
7(2) | Jairam Sridharan | 2994875 | Buy |
Annual Reports of Piramal Enterprises Limited
Investor Complaints of Piramal Enterprises Limited
Date | Pending | Received | Disposed | Unresolved |
---|---|---|---|---|
31-Dec-2024 | 0 | 13 | 12 | 1 |
30-Sep-2024 | 3 | 16 | 19 | 0 |
30-Jun-2024 | 0 | 14 | 11 | 3 |
31-Mar-2024 | 2 | 8 | 10 | 0 |
31-Dec-2023 | 0 | 18 | 16 | 2 |
30-Sep-2023 | 1 | 8 | 9 | 0 |
30-Jun-2023 | 1 | 18 | 18 | 1 |
31-Mar-2023 | 2 | 13 | 14 | 1 |
31-Dec-2022 | 1 | 9 | 8 | 2 |
30-Sep-2022 | 0 | 20 | 19 | 1 |
30-Jun-2022 | 0 | 8 | 8 | 0 |
31-Mar-2022 | 1 | 5 | 6 | 0 |
31-Dec-2021 | 0 | 2 | 1 | 1 |
30-Sep-2021 | 0 | 4 | 4 | 0 |
30-Jun-2021 | 3 | 5 | 8 | 0 |
31-Mar-2021 | 1 | 5 | 3 | 3 |
31-Dec-2020 | 1 | 6 | 6 | 1 |
30-Sep-2020 | 3 | 5 | 7 | 1 |
30-Jun-2020 | 0 | 4 | 1 | 3 |
31-Mar-2020 | 0 | 8 | 8 | 0 |
31-Dec-2019 | 3 | 6 | 9 | 0 |
30-Sep-2019 | 0 | 8 | 5 | 3 |
30-Jun-2019 | 1 | 7 | 8 | 0 |
31-Mar-2019 | 0 | 9 | 8 | 1 |
31-Dec-2018 | 2 | 9 | 11 | 0 |
30-Sep-2018 | 3 | 12 | 13 | 2 |
30-Jun-2018 | 1 | 8 | 6 | 3 |
31-Mar-2018 | 5 | 10 | 14 | 1 |
31-Dec-2017 | 1 | 11 | 8 | 4 |
30-Sep-2017 | 4 | 3 | 6 | 1 |
30-Jun-2017 | 1 | 6 | 3 | 4 |
31-Mar-2017 | 3 | 1 | 3 | 1 |
31-Dec-2016 | 2 | 3 | 2 | 3 |
30-Sep-2016 | 1 | 7 | 6 | 2 |
30-Jun-2016 | 1 | 7 | 7 | 1 |
31-Mar-2016 | 1 | 3 | 3 | 1 |
31-Dec-2015 | 2 | 1 | 2 | 1 |
Event Calendar of Piramal Enterprises Limited
Purpose | Details |
---|---|
Results | To consider and take on record the Audited Financial Results of NPIL and the Unaudited Consolidated Results for the First Quarter ended June 30, 2005. |
Financial Results | To consider and take on record the Audited Financial Results and the un-audited consolidated results of the Company for the second quarter and half-year ended September 30, 2005. |
Financial Results | To consider and take on record the Financial Results of the Company (consolidated and stand-alone) for the 1st Quarter ended June 30, 2007. |
Scheme of Arrangement | To consider a proposal for restructuring the Company's R&D Division by de-merging its New Chemical Entity (NCE) Research Unit into a separate entity under a Scheme of Arrangement. |
Financial Results | To consider and take on record the Financial Results (consolidated and standalone) of the Company for the 2nd quarter and half-year ended September 30, 2010. |
Results/Dividend/Buyback | The company had informed the Exchange regarding Board Meeting to be held on October 22, 2010 to consider and take on record the Financial Results (consolidated and standalone) of the Company for the 2nd quarter and half-year ended September 30, 2010. The company has now informed the Exchange that at the Board Meeting, the Board would also consider various options for rewarding shareholders of the Company, including by way of a dividend and/or a buy-back of equity shares. |
Results/Dividend | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 06, 2011 (1) To consider and approve the Audited Financial Results (consolidated & stand-alone) of the Company for the financial year ended March 31, 2011; (2) To consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2011. The Company has now informed the Exchange that at the aforesaid Board Meeting on May 06, 2011, the Board would also be considering a proposal for Demerger of the New Chemical Entity (NCE) Research Unit of Piramal Life Sciences Limited ('PLSL') into the Company. The Company has a 17.88% equity stake in PLSL. (Purpose Revised). |
Results/Dividend | (1) To consider and approve the Audited Financial Results (consolidated & stand-alone) of the Company for the financial year ended March 31, 2011; (2) To consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2011. |
Financial Results | To consider and take on record the Financial Results (consolidated and standalone) of the Company for the 2nd quarter and half-year ended September 30, 2011. |
Results/Dividend | To consider and approve the Audited Financial Results (Consolidated & stand-alone) of the Company for the financial year ended March 31, 2012. The Board would also consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2012. |
Results | To consider and take on record the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2012, which would be subjected to Limited Review by the Auditors of the Company. |
Results/Dividend | To consider and approve the Audited Financial Results (Consolidated & stand-alone) of the Company for the financial year ended March 31, 2013. The Board would also consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2013. |
Results | inter alia, to consider and take on record the Unaudited Financial Results (Consolidated and Standalone) of the Company for the Quarter ended June 30, 2013. |
Results | to consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended September 30, 2013. |
Results | To consider and take on record the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2013, which would be subjected to Limited Review by the Auditors of the Company. Further, the Trading Window for dealing in the securities of the Company by the its Directors /Officers / Designated Employees will remain closed from January 22, 2014 to January 31, 2014 in terms of clause 3.2.3 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 and clause V of Code for Prevention of Insider Trading in Securities of the Company. |
Results | To consider and approve the Audited Financial Results (Consolidated and Standalone) of the Company for the Financial Year ended 31st March, 2014. |
Results/Dividend | The Company had informed the Exchange that the 'Trading Window' for dealing in the securities of the Company by the Directors / Officers / Designated Employees of the Company will remain closed from April 01, 2014 and shall remain closed until the expiry of one day after the publication of the audited financial results of the Company for the financial year ended March 31, 2014.The Board is scheduled to meet on May 05, 2014 for considering and approving the financial results for the financial year ended March 31, 2014. Accordingly, the Trading Window shall remain closed till and including May 06, 2014.The Company has now informed the Exchange that the Board would also consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2014. (purpose revised) |
Results | The Company has informed the Exchange that the 'Trading Window' for dealing in the securities of the Company by the Directors / Officers / Designated Employees of the Company will remain closed from April 01, 2014 and shall remain closed until the expiry of one day after the publication of the audited financial results of the Company for the financial year ended March 31, 2014.The Board is scheduled to meet on May 05, 2014 for considering and approving the financial results for the financial year ended March 31, 2014. Accordingly, the Trading Window shall remain closed till and including May 06, 2014. |
Results | To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended 30th June, 2014. The Trading Window for dealing in the securities of the Company by its Directors/Officers/Designated Employees of the Company is closed from today, Tuesday July 29, 2014 to Thursday, August 7, 2014 in terms of clause 3.2.3 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 and clause V of Code for Prevention of Insider Trading in Securities of the Company. |
Results | To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended September 30, 2014.The results shall be subject to limited review.Furher, that the Trading Window for dealing in the securities of the Company by its Directors/Officers/Designated Employees of the Company is closed from Tuesday, October 14, 2014 to October 22, 2014 in terms of clause 3.2.3 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 and clause V of Code for Prevention of Insider Trading in Securities of the Company. |
Results | To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2014. |
Results/Dividend | To consider and approve the Audited Financial Results (Consolidated & stand-alone) of the Company for the financial year ended March 31, 2015. The Board would also consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2015. |
Results | to consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, 2015. |
Results | to consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended 30th September, 2015. |
Results | To consider and approve the Unaudited Financial Results (consolidated and standalone) of the Company for the quarter and nine months ended December 31, 2015. |
Dividend | to consider and approve declaration of interim dividend. |
Results | To consider and approve the Audited Financial Results (Consolidated and Standalone) of the Company for the financial year ended March 31, 2016. |
Others | To consider and approve the issue on private placement basis of Secured Non-Convertible Debentures amounting upto Rs. 300 crores. |
Results | to consider and approve the Unaudited Financial Results(Consolidated and Standalone) of the Company for the quarter ended June 30, 2016. |
Issue of Securities | To consider and approve the issue on private placement basis of secured non-convertible debentures aggregating to Rs. 80 crores in one or more issues from time to time. |
Results | to consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended September 30, 2016. |
Results | To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2016. |
Results/Others | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 12, 2017 To consider and approve the Audited Financial Results (Consolidated and Standalone) of the Company for the financial year ended March 31, 2017. The Company has now informed the Exchange that the aforesaid Board Meeting shall also consider among other items, approval of raising or funds by issue or equity shares, convertible securities or any other securities (including foreign securities) by way of one or more public, rights and/or private offerings as may be permitted under applicable law, subject to such approvals as may be required. and to approve ancillary actions for the above-mentioned fund raising including approval or the postal ballot notice for obtaining shareholders ' approval.(Purpose Revised) |
Results | To consider and approve the Audited Financial Results (Consolidated and Standalone) of the Company for the financial year ended March 31, 2017. |
Results | to consider and approve the Unaudited Financial Results( Consolidated and Standalone) of the Company for the quarter ended June 30, 2017. |
Raising of Funds | to inter alia consider the following proposals: 1) Various fund raising options for the Company,as the Board may deem appropriate and to the extent applicable or if considered by the Board, pricing of any securities proposed to be allotted by the Company; 2) Scheme of Amalgamation of wholly-owned subsidiaries of the Company, Piramal Finance Limited ( PEL) and Piramal Capital Limited with Piramal Housing Finance Private Limited, wholly owned subsidiary of PFL |
Results | To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter & half year ended September 30, 2017. |
Results | To consider and approve the unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2017. |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend on equity shares, if any, for the said year. |
Financial Results | To consider and approve the Unaudited Financial Results for the period ended Jun 30, 2018ᅡᅠand closure of trading window |
Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
Other business matters | To consider amendment to the terms of issue of Non-convertible Debentures issued vide Information Memorandum dated November 15, 2018 and November 28, 2018. |
Financial Results | To consider and approve the Unaudited financial results for the quarter and nine months ended December 31, 2018 |
Financial Results/Dividend | To consider and approve the audited financial results for the period ended March 31, 2019 and recommendation of dividend on equity shares, if any, for the said year |
Financial Results | To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended 30th June, 2019. |
Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
Fund Raising | To consider Fund Raising |
Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
Dividend | To consider Interim Dividend |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
Financial results | Piramal Enterprises Limited has informed the Exchange about Board Meeting to be held on 29-Jul-2022 to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2022.In this regard, we write to inform you that the ¬タリTrading Window¬タル for dealing in the securities of the Company has been closed from Friday, 1st July, 2022 and will remain closed till Sunday, 31st July, 2022 (both days inclusive). |
Financial results | Piramal Enterprises Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2022 to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2022.In this regard, we write to inform you that the ¬タリTrading Window¬タル for dealing in the securities of the Company has been closed from Saturday, 1st October, 2022 and will remain closed till Friday, 11th November, 2022 (both days inclusive). |
Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
Dividend | In continuation of our letter dated 28th April, 2023, regarding intimation of the Board Meeting of the Company to be held on Friday, 5th May, 2023, for consideration of Audited Financial Results (Standalone and Consolidated) of the Company for the financial year ended 31st March, 2023, we would like to inform you that the Board of Directors of the Company, in its aforesaid meeting, will also consider recommending to the shareholders, payment of dividend on the equity shares of the Company for the said year. |
Financial Results | To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the financial year ended 31st March, 2023. In this regard, we write to inform you that the Trading Window for dealing in the securities of the Company has been closed from Saturday, 1st April, 2023 and will remain closed till Sunday, 7th May, 2023 (both days inclusive). |
Financial Results | To consider and approve the Un-audited financial results for the quarter ended Jun 30, 2023 |
Buyback | To consider buyback for equity shares |
Financial Results | To consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023 |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Financial Results/Dividend | To consider and approve Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March, 2024 and recommendation of dividend on equity shares, if any, for the said year |
Financial Results/Other business matters | To consider and approve the financial results for the period ended June 30, 2024 and other business matters |
Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Piramal Enterprises Limited
Voting Results of Piramal Enterprises Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
08-JUL-2024 | AGM | To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2024 |
08-JUL-2024 | AGM | Payment of Commission to Non-Executive Directors of the Company |
08-JUL-2024 | AGM | Payment of Commission to Non-Executive Directors of the Company |
08-JUL-2024 | AGM | Issue of Non-Convertible Debentures on Private Placement Basis |
08-JUL-2024 | AGM | Appointment of Mr. Asheet Mehta (DIN:10648593) as an Independent Director of the Company |
08-JUL-2024 | AGM | To appoint a Director in place of Mr. Anand Piramal (DIN: 00286085), who retires by rotation and being eligible, offers himself for re-appointment |
08-JUL-2024 | AGM | To declare final dividend on equity shares for the financial year ended March 31, 2024. |
30-JUN-2023 | AGM | Adoption of Audited Financial Statements (Standalone and Consolidated) and the Reports of the Board of Directors and Auditors thereon of the Company for the financial year ended on March 31, 2023. |
30-JUN-2023 | AGM | Issue of Non-Convertible Debentures on Private Placement Basis |
30-JUN-2023 | AGM | Re-appointment of Mr. Vijay Shah (DIN: 00021276), who retires by rotation and being eligible, offers himself for re-appointment. |
30-JUN-2023 | AGM | Declaration of Final Dividend of Rs. 31/- per equity share of face value Rs. 2/- each for the financial year ended March 31, 2023. |
11-DEC-2022 | Postal Ballot | Appointment of Bagaria & Co LLP, Chartered Accountants as the Joint Statutory Auditors of the Company |
11-DEC-2022 | Postal Ballot | Appointment of Mr. Gautam Doshi as an Independent Director. |
29-JUL-2022 | AGM | To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended on March 31, 2022 and the Reports of the Board of Directors and Auditors thereon |
29-JUL-2022 | AGM | Issue of Non-Convertible Debentures on Private Placement Basis |
29-JUL-2022 | AGM | Ratification of remuneration payable to the Cost Auditor |
29-JUL-2022 | AGM | Appointment of Mr. Rajiv Mehrishi as an Independent Director |
29-JUL-2022 | AGM | Appointment of M/s. Suresh Surana & Associates LLP, Chartered Accountants as Statutory Auditors of the Company |
29-JUL-2022 | AGM | To appoint Director in place of Dr. (Mrs.) Swati A. Piramal (DIN: 00067125) who retires by rotation and being eligible, offers herself for re-appointment |
29-JUL-2022 | AGM | To declare final dividend on equity shares for the financial year ended March 31, 2022 |